Physiology of Calcium and Phosphate Homeostases

Dynamics of Bone and Cartilage Metabolism

Volumn , Issue , 2006, Pages 345-360

  Rizzoli, René ^a   Bonjour, Jean Philippe ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Faculty of Medicine   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76249098193     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088562-6/50021-2     Document Type: Chapter

References (120)

1. Broadus A.E. Mineral balance and homeostasis. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2003, 105-111. American Society for Bone and Mineral Research, Washington, D.C. M.J. Favus (Ed.).
2. Brown E.M., MacLeod R.J. Extracellular calcium sensing and extracellular calcium signaling. Physiol. Rev. 2001, 81:239-297.
3. Bonjour J.P., Theintz G., Buchs B., Slosman D., Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J. Clin. Endocrinol. Metab. 1991, 73:555-563.
4. Theintz G., Buchs B., Rizzoli R., Slosman D., Clavien H., Sizonenko P.C., Bonjour J.P. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J. Clin. Endocrinol. Metab. 1992, 75:1060-1065.
5. Bonjour J.P., Rizzoli R. Bone acquisition in adolescence. Osteoporosis 2001, 621-638. Academic Press, San Diego, CA. R. Marcus, D. Feldman, J. Kelsey (Eds.).
6. Blair H.C., Robinson L.J., Zaidi M. Osteoclast signalling pathways. Biochem. Biophys. Res. Commun. 2005, 328:728-738.
7. Parekh A.B., Putney J.W. Store-operated calcium channels. Physiol. Rev. 2005, 85:757-810.
8. + as an extracellular signal in bone. Cell Calcium 2004, 35:249-255.
9. Szabadkai G., Rizzuto R. Participation of endoplasmic reticulum and mitochondrial calcium handling in apoptosis: more than just neighborhood?. FEBS Lett. 2004, 567:111-115.
10. Reeves J.P., Condrescu M., Chemaya G., Gardner J.P. Na+/Ca2+ antiport in the mammalian heart. J. Exp. Biol. 1994, 196:375-388.
11. Carafoli E. Calcium signaling: a tale for all seasons. Proc. Natl. Acad. Sci. USA 2002, 99:1115-1122.
12. Carafoli E. Calcium-mediated cellular signals: a story of failures. Trends Biochem. Sci. 2004, 29:371-379.
13. Rodland K.D. The role of the calcium-sensing receptor in cancer. Cell Calcium 2004, 35:291-295.
14. McConkey D.J., Orrenius S. The role of calcium in the regulation of apoptosis. J. Leukoc. Biol. 1996, 59:775-783.
15. Rizzoli R., Fleisch H., Bonjour J.P. Effect of thyroparathyroidectomy of calcium metabolism in rats: role of 1,25-dihydroxyvitamin D3. Am. J. Physiol. 1977, 233:E160-E164.
16. Lopez-Hilker S., Dusso A.S., Rapp N.S., Martin K.J., Slatopolsky E. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am. J. Physiol. 1990, 259:F432-F437.
17. Hoenderop J.G., Nilius B., Bindels R.J. Calcium absorption across epithelia. Physiol. Rev. 2005, 85:373-422.
18. Holick M.F. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2003, 129-137. American Society for Bone and Mineral Research, Washington, D.C. M.J. Favus (Ed.).
19. Feldman D., Malloy P.J., Gross C. Biology, action, and clinical implications. Osteoporosis 2001, 257-303. Academic Press, San Diego, CA. R. Marcus, D. Feldman, J. Kelsey (Eds.).
20. Bonjour J.P., Fleisch H., Trechsel U. Calcium absorption in diphosphonate-treated rats: effect of parathyroid function, dietary calcium and phosphorus. J. Physiol. 1977, 264:125-139.
21. Rizzoli R., Fleisch H., Bonjour J.P. Role of 1,25-dihydroxyvitamin D3 on intestinal phosphate absorption in rats with a normal vitamin D supply. J. Clin. Invest. 1977, 60:639-647.
22. Heaney R.P., Weaver C.M., Recker R.R. Calcium absorbability from spinach. Am. J. Clin. Nutr. 1988, 47:707-709.
23. Heaney R.P., Weaver C.M. Calcium absorption from kale. Am. J. Clin. Nutr. 1990, 51:656-657.
24. Ammann P., Rizzoli R., Fleisch H. Calcium absorption in rat large intestine in vivo: availability of dietary calcium. Am. J. Physiol. 1986, 251:G14-G18.
25. Pak C.Y., Kaplan R., Bone H., Townsend J., Waters O. A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N. Engl. J. Med. 1975, 292:497-500.
26. Lemann J., Favus M.J. Intestinal absorption of calcium, magnesium and phosphate. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2003, 93-97. American Society for Bone and Mineral Research, Washington, D.C. M.J. Favus (Ed.).
27. Hefti E., Trechsel U., Fleisch H., Bonjour J.P. Nature of calcemic effect of 1,25-dihydroxyvitamin D3 in experimental hypoparathyroidism. Am. J. Physiol. 1983, 244:E313-E316.
28. Jüppner H., Kronenberg H.M. Parathyroid homrmone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2003, 117-124. American Society for Bone and Mineral Research, Washington, D.C. M.J. Favus (Ed.).
29. Mundy G.R., Chen D., Oyajobi B.O. Bone remodeling. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2003, 46-58. American Society for Bone and Mineral Research, Washington, D.C. M.J. Fayus (Ed.).
30. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 2000, 21:115-137.
31. Martin T.J., Rodan G.A. Coupling of bone resorption and formation during bone remodeling. Osteoporosis 2001, 361-371. Academic Press, San Diego, CA. R. Marcus, D. Feldman, J. Kelsey (Eds.).
32. Holbauer L.C., Schoppet M. Clinical implications of the osteoprote gerin/RANKL/RANK system for bone and vascular diseases. JAMA 2004, 292:490-495.
33. Peacock M., Robertson W.G., Nordin B.E. Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet 1969, 1:384-386.
34. Nordin B.E., Peacock M. Role of kidney in regulation of plasma-calcium. Lancet 1969, 2:1280-1283.
35. Bonjour J.P., Philippe J., Guelpa G., Bisetti A., Rizzoli R., Jung A., Rosini S., Kanis J.A. Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate. Bone 1988, 9:123-130.
36. Parsons J.A., Robinson C.J. Calcium shift into bone causing transient hypocalcaemia after injection of parathyroid hormone. Nature 1971, 230:581-582.
37. Parsons J.A., Neer R.M., Potts J.T. Initial fall of plasma calcium after intravenous injection of parathyroid hormone. Endocrinology 1971, 89:735-740.
38. Friedman P.A. Mechanisms of renal calcium transport. Exp. Nephrol. 2000, 8:343-350.
39. Marx S.J., Spiegel A.M., Levine M.A., Rizzoli R.E., Lasker R.D., Santora A.C., Downs R.W., Aurbach G.D. Familial hypocalciuric hypercalcemia: the relation to primary parathyroid hyperplasia. N. Engl. J. Med. 1982, 307:416-426.
40. Attie M.F., Gill J.R., Stock J.L., Spiegel A.M., Downs R.W., Levine M.A., Marx S.J. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. J. Clin. Invest. 1983, 72:667-676.
41. Thakker R.V. Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 2004, 35:275-282.
42. Rizzoli R., Hugi K., Fleisch H., Bonjour J.P. Effect of hydrochlorothiazide on 1,25-dihydroxyvitamin D3-induced changes in calcium metabolism in experimental hypoparathyroidism in rats. Clin. Sci. (Lond.) 1981, 60:101-107.
43. Rizzoli R., Pizurki L., Bonjour J.P. Tumoral parathyroid homone-related protein: a new hormone affecting calcium and phosphate transport. NIPS 1989, 4:195-198.
44. Strewler G.J., Nissenson R.A. Parathyroid homone-related protein. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2003, 125-129. American Society for Bone and Mineral Research, Washington, D.C. M.J. Favus (Ed.).
45. Bisello A., Horwitz M.J., Stewart A.F. Parathyroid hormone-related protein: an essential physiological regulator of adult bone mass. Endocrinology 2004, 145:3551-3553.
46. Caverzasio J., Rizzoli R., Vallotton M.B., Dayer J.M., Bonjour J.P. Stimulation by interleukin-1 of renal calcium reabsorption in thyroparathyroidectomized rats. J. Bone Miner. Res. 1993, 8:1219-1225.
47. Pizurki L., Rizzoli R., Caverzasio J., Bonjour J.P. Effect of transforming growth factor-alpha and parathyroid hormone-related protein on phosphate transport in renal cells. Am. J. Physiol. 1990, 259:F929-F935.
48. Law F., Rizzoli R., Bonjour J.P. Transforming growth factor-beta inhibits phosphate transport in renal epithelial cells. Am. J. Physiol. 1993, 264:F623-F628.
49. Law F., Bonjour J.P., Rizzoli R. Transforming growth factor-beta: a down-regulator of the parathyroid hormone-related protein receptor in renal epithelial cells. Endocrinology 1994, 134:2037-2043.
50. Buchs B., Rizzoli R., Bonjour J.P. Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia. Bone 1991, 12:47-56.
51. Rizzoli R., Stoermann C., Ammann P., Bonjour J.P. Hypercalcemia and hyperosteolysis in vitamin D intoxication: effects of clodronate therapy. Bone 1994, 15:193-198.
52. Rizzoli R., Caverzasio J., Chapuy M.C., Martin T.J., Bonjour J.P. Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in rats. J. Bone Miner. Res. 1989, 4:759-765.
53. Rizzoli R., Caverzasio J., Bauss F., Bonjour J.P. Inhibition of bone resorption by the bisphosphonate BM21.0955 is not associated with an alteration of the renal handling of calcium in rats infused with parathyroid hormone-related protein. Bone 1992, 13:321-325.
54. Hirschel-Scholz S., Caverzasio J., Bonjour J.P. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent. J. Clin. Invest. 1985, 76:1851-1856.
55. Hirschel-Scholz S., Caverzasio J., Rizzoli R., Bonjour J.P. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721. J. Clin. Invest. 1986, 78:319-322.
56. Chen R.A., Goodman W.G. Role of the calcium-sensing receptor in parathyroid gland physiology. Am. J. Physiol. Renal. Physiol. 2004, 286:F1005-F1011.
57. Brown E.M., Gamba G., Riccardi D., Lombardi M., Butters R., Kifor O., Sun A., Hediger M.A., Lytton J., Hebert S.C. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993, 366:575-580.
58. Hu J., Spiegel A.M. Naturally occurring mutations of the extracellular Ca2+-sensing receptor: implications for its structure and function. Trends Endocrinol. Metab. 2003, 14:282-288.
59. Brown E.M., Pollak M.R., Hebert S.C. The extracellular calcium-sensing receptor, its role in health and disease. Annu. Rev. Med. 1998, 49:15-29.
60. 2+ sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993, 75:1297-1303.
61. Ho C., Conner D.A., Pollak M.R., Ladd D.J., Kofor O., Warren H.B., Brown E.M., Seidman J.G., Seidman C.E. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat. Genet. 1995, 11:389-394.
62. Mallette L.E., Eichhorn E. Effects of lithium carbonate on human calcium metabolism. Arch. Intern. Med. 1986, 146:770-776.
63. Bendz H., Sjodin I., Toss G., Berglund K. Hyperparathyroidism and long-term lithium therapy-across-sectional study and the effect of lithium withdrawal. J. Intern. Med. 1996, 240:357-365.
64. House M.G., Kohlmeier L., Chattopadhyay N., Kifor O., Yamaguchi T., Leboff M.S., Glowacki J., Brown E.M. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J. Bone Miner. Res. 1997, 12:1959-1970.
65. Sands J.M., Naruse M., Baum M., Jo I., Hebert S.C., Brown E.M., Harris H.W. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J. Clin. Invest. 1997, 99:1399-1405.
66. Chattopadhyay N., Cheng I., Rogers K., Riccardi D., Hall A., Diaz R., Hebert S.C., Soybel D.I., Brown E.M. Identification and localization of extracellular Ca(2+)-sensing receptor in rat intestine. Am. J. Physiol. 1998, 274:G122-G130.
67. Buchs N., Manen D., Bonjour J.P., Rizzoli R. Calcium stimulates parathyroid hormone-related protein production in Leydig tumor cells through a putative cation-sensing mechanism. Eur. J. Endocrinol. 2000, 142:500-505.
68. Quarles L.D., Hartle J.E., Siddhanti S.R., Guo R., Hinson T.K. A distinct cation-sensing mechanism in MC3T3-E1 osteoblasts functionally related to the calcium receptor. J. Bone Miner. Res. 1997, 12:393-402.
69. Pi M., Quarles L.D. A novel cation-sensing mechanism in osteoblasts is a molecular target for strontinum. J. Bone. Miner. Res. 2004, 19:862-869.
70. Yamaguchi T., Kifor O., Chattopadhyay N., Brown E.M. Expression of extracellular calcium (Ca2+o)-sensing receptor in the clonal osteoblast-like cell lines, UMR-106 and SAOS-2. Biochem. Biophys. Res. Commun. 1998, 243:753-757.
71. Gallagher J.C., Riggs B.L., Eisman J., Hamstra A., Arnaud S.B., DeLuca H.F. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J. Clin. Invest. 1979, 64:729-736.
72. Ebeling P.R., Sandgren M.E., DiMagno E.P., Lane A.W., DeLuca H.F., Riggs B.L. Evidence fo an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J. Clin. Endocrinol. Metab. 1992, 75:176-182.
73. Johnston C.C., Miller J.Z., Slemenda C.W., Reister T.K., Hui S., Christian J.C., Peacock M. Calcium supplementation and increases in bone mineral density in children. N. Engl. J. Med. 1992, 327:82-87.
74. Lloyd T., Andon M.B., Rollings N., Martel J.K., Landis J.R., Demers L.M., Eggli D.F., Kieselhorst K., Kulin H.E. Calcium supplementation and bone mineral density in adolescent girls. JAMA 1993, 270:841-844.
75. Lee W.T., Leung S.S., Xu Y.C., Wang S.H., Zeng W.P., Lau J., Fairweather-Tait S.J. Effects of double-blind controlled calcium supplementation on calcium absorption in Chinese children measured with stable isotopes (42Ca and 44Ca). Br. J. Nutr. 1995, 73:311-321.
76. Bonjour J.P., Carrie A.L., Ferrari S., Clavien H., Slosman D., Theintz G., Rizzoli R. Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebocontrolled trial. J. Clin. Invest. 1997, 99:1287-1294.
77. Chevalley T., Rizzoli R., Hans D., Ferrari S., Bonjour J.P. Interaction between calcium intake and menarcheal age on bone mass gain: an eight-year follow-up study from prepuberty to postmenarche. J. Clin. Endocrinol. Metab. 2005, 90:44-51.
78. Chevalley T., Bonjour J.P., Ferrari S., Hans D., Rizzoli R. Skeletal site selectivity in the effects of calcium supplementation on areal bone mineral density gain: a randomized, double-blind, placebo-controlled trial in prepubertal boys. J. Clin. Endocrinol. Metab. 2005, 90:3342-3349.
79. Ferrari S.L., Rizzoli R., Slosman D.O., Bonjour J.P. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms?. J. Bone Miner. Res. 1998, 13:363-370.
80. Boonen S., Rizzoli R., Meunier P.J., Stone M., Nuki G., Syversen U., Lehtonen-Veromaa M., Lips P., Johnell O., Reginster J.Y. The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int. 2004, 15:511-519.
81. Shea B., Wells G., Cranney A., Zytaruk N., Robinson V., Griffith L., Hamel C., Ortiz Z., Peterson J., Adachi J., Tugwell P., Guyatt G. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst. Rev. 2003, CD004526.
82. Shea B., Wells G., Cranney A., Zytaruk N., Robinson V., Griffith L., Hamel C., Ortiz Z., Peterson J., Adachi J., Tugwell P., Guyatt G. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst. Rev. 2004, CD004526.
83. Chapuy M.C., Arlot M.E., Duboeuf F., Brun J., Crouzet B., Arnaud S., Delmas P.D., Meunier P.J. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N. Engl. J. Med. 1992, 327:1637-1642.
84. Chevalley T., Rizzoli R., Nydegger V., Slosman D., Rapin C.H., Michel J.P., Vasey H., Bonjour J.P. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos. Int. 1994, 4:245-252.
85. Dawson-Hughes B., Harris S.S., Krall E.A., Dallal G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N. Engl. J. Med. 1997, 337:670-676.
86. Honda Y., Fitzismmons R.J., Baylink D.J., Mohan S. Effects of extracellular calcium on insulin-like growth factor II in human bone cells. J. Bone Miner. Res. 1995, 10:1660-1665.
87. Yoo A., Tanimoto H., Akesson K., Baylink D.J., Lau K.H. Effects of calcium depletion and repletion on serum insulin-like growth factor I and binding protein levels in weanling rats. Bone 1998, 22:225-232.
88. Murer H., Hernando N., Forster I., Biber J. Regulation of Na/Pi transporter in the proximal tubule. Annu. Rev. Physiol. 2003, 65:531-542.
89. Bacic D., Wagner C.A., Hernando N., Kaissling B., Biber J., Murer H. Novel aspects in regulated expression of the renal type IIa Na/Pi-cotransporter. Kidney Int. Suppl. 2004, S5-S12.
90. Pizurki L., Rizzoli R., Caverzasio J., Bonjour J.P. Stimulation by parathyroid hormone-related protein and transforming growth factor-alpha of phosphate transport in osteoblast-like cells. J. Bone Miner. Res. 1991, 6:1235-1241.
91. Montessuit C., Bonjour J.P., Caverzasio J. Expression and regulation of Na-dependent P(i) transport in matrix vesicles produced by osteoblast-like cells. J. Bone Miner. Res. 1995, 10:625-631.
92. Caverzasio J., Bonjour J.P. Characteristies and regulation of Pi transport in osteogenic cells for bone metabolism. Kidney Int. 1996, 49:975-980.
93. Kavanaugh M.P., Miller D.G., Zhang W., Law W., Kozak S.L., Kabat D., Miller A.D. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA 1994, 91:7071-7075.
94. Palmer G., Bonjour J.P., Caverzasio J. Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I. Endocrinology 1997, 138:5202-5209.
95. Bonjour J.P., Caverzasio J. Phosphate transport in the kidney. Rev. Physiol. Biochem. Pharmacol. 1984, 100:161-214.
96. Custer M., Spindler B., Verrey F., Murer H., Biber J. Identification of a new gene product (diphor-1) regulated by dietary phosphate. Am. J. Physiol. 1997, 273:F801-F806.
97. The HYP Consortium A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat. Genet. 1995, 11:130-136.
98. Du L., Desbarats M., Viel J., Glorieux F.H., Cawthorn C., Ecarot B. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 1996, 36:22-28.
99. Econs M.J., Francis F. Positional cloning of the PEX gene: new insights into the pathophysiology of X-linked hypophosphatenic rickets. Am. J. Physiol. 1997, 273:F489-F498.
100. Trohler U., Bonjour J.P., Fleisch H. Inorganic phosphate homeostasis. Renal adaptation to the dietary intake in intact and thyroparathyroidectomized rats. J. Clin. Invest. 1976, 57:264-273.
101. Trohler U., Bonjour J.P., Fleisch H. Renal tubular adaptation to dietary phosphorus. Nature 1976, 261:145-146.
102. Caverzasio J., Rizzoli R., Bonjour J.P. Sodium-dependent phosphate transport inhibited by parathyroid hormone and cyclic AMP stimulation in an opossum kidney cell line. J. Biol. Chem. 1986, 261:3233-3237.
103. Caverzasio J., Bonjour J.P. Insulin-like growth factor 1 stimulates Na-dependent Pi transport in cultured kidney cells. Am. J. Physiol. 1989, 257:F712-F717.
104. Pizurki L., Rizzoli R., Moseley J., Martin T.J., Caverzasio J., Bonjour J.P. Effect of synthetic tumoral PTH-related peptide on cAMp production and Na-dependent Pi transport. Am. J. Physiol. 1988, 255:F957-F961.
105. Caverzasio J., Montessuit C., Bonjour J.P. Stimulatory effect of insulin-like growth factor-1 on renal Pi transport and plasma 1,25-dihydroxyvitamin D3. Endocrinology 1990, 127:453-459.
106. Dunstan C.R., Zhou H., Seibel M.J. Fibroblast growth factor 23: a phosphatonin regulating phosphate homeostasis?. Endocrinology 2004, 145:3084-3086.
107. Schiavi S.C., Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int. 2004, 65:1-14.
108. Riminucci M., Collins M.T., Fedarko N.S., Cherman N., Corsi A., White K.E., Waguespack S., Gupta A., Hannon T., Econs M.J., Bianco P., Gehron Robey P. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J. Clin. Invest. 2003, 112:683-692.
109. Berndt T., Craig T.A., Bowe A.E., Vassiliadis J., Reczek D., Finnegan R., Jan De Beur S.M., Schiavi S.C., Kumar R. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J. Clin.Invest. 2003, 112:785-794.
110. Quarles L.D. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E1-E9.
111. Marinella M.A. Refeeding syndrome and hypophosphatemia. J. Intensive Care Med. 2005, 20:155-159.
112. Takeda E., Yamamoto H., Nashiki K., Sato T., Arai H., Taketani Y. Inorganic phosphate homeostasis and the role of dietary phosphorus. J. Cell. Mol. Med. 2004, 8:191-200.
113. Bohannon N.J. Large phosphate shifts with treatment for hyperglycemia. Arch. Intern. Med. 1989, 149:1423-1425.
114. Jones D.P., Mahmoud H., Chesney R.W. Tumor lysis syndrome: pathogenesis and management. Pediatr. Nephrol. 1995, 9:206-212.
115. Hruska K.A., Rifas L., Cheng S.L., Gupta A., Halstead L., Avioli L. X-linked hypophosphatemic rickets and the murine Hyp homologue. Am. J. Physiol. 1995, 268:F357-F362.
116. Ferrari S.L., Bonjour J.P., Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J. Clin. Endocrinol. Metab. 2005, 90:1519-1524.
117. Buchs N., Bonjour J.P., Rizzoli R. Renal tubular reabsorption of phosphate is positively related to the extent of bone metastatic load in patients with prostate cancer. J. Clin. Endocrinol. Metab. 1998, 83:1535-1541.
118. Caverzasio J., Gloor H.J., Fleisch H., Bonjour J.P. Parathyroid hormone-independent adaptation of the renal handling of phosphate in response to renal mass reduction. Kidney Int. 1982, 21:471-476.
119. Bonjour J.P., Caverzasio J., Rizzoli R. Phosphate homeostasis, 1,25-dihydroxyvitamin D3, and hyperparathyroidism in early chronic renal failure. Trends Endocrinol. Metab. 1992, 3:391-395.
120. Slatopolsky E., Finch J., Denda M., Ritter C., Zhong M., Dusso A., MacDonald P.N., Brown A.J. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J. Clin. Invest. 1996, 97:2534-2540.